Year archive

Alvotech Holdings S.A — 2026 filings

All 58 regulatory filings released by Alvotech Holdings S.A (ALVO) in 2026, sourced directly from the official regulator.

58 Filings

2026 Period

2026 filings (58)

Filing	Released	Lang
6-K - Alvotech (0001898416) (Filer) Regulatory Filings	2026-05-11	English
Matvæla- og lyfjaeftirlit Bandaríkjanna lýkur úttekt á framleiðsluaðstöðu Alvotech Regulatory Filings	2026-05-11	Icelandic
Alvotech announces completion of FDA surveillance inspection at Reykjavik facility Regulatory Filings	2026-05-11	English
Alvotech birtir uppgjör fyrsta ársfjórðungs 2026 Interim / Quarterly Report	2026-05-06	Icelandic
Alvotech Q1 2026 Financial Results Interim / Quarterly Report	2026-05-06	English
6-K - Alvotech (0001898416) (Filer) Regulatory Filings	2026-05-04	English
Alvotech tilkynnir breytingu í framkvæmdastjórn Board/Management Information	2026-04-30	Icelandic
Alvotech Announces a Change in its Executive Team Board/Management Information	2026-04-30	English
222100dczbowv5dz8372-2025-12-31-1-en (2) Annual Report FY 2025	2026-04-30	English
Alvotech Lux standalone 2025 with responsibility statement Annual Report FY 2025	2026-04-30	English
222100DCZBOWV5DZ8372-2025-12-31-1-en Annual Report FY 2025	2026-04-30	English
Alvotech birtir uppgjör fyrsta ársfjórðungs 2026 þann 6. maí nk. Report Publication Announcement	2026-04-24	Icelandic
Alvotech to Report Financial Results for the First Quarter of 2026 Report Publication Announcement	2026-04-24	English
Alvotech S.A. - Consolidated Financial Statements_31.12.2025 Regulatory Filings	2026-04-23	English
Viðskipti stjórnenda og tengdra aðila Director's Dealing	2026-04-01	Icelandic
Transactions of Managers and Closely Associated Persons Director's Dealing	2026-04-01	English
l Director's Dealing	2026-04-01	English
r Director's Dealing	2026-04-01	English
Viðskipti stjórnenda og tengdra aðila Director's Dealing	2026-04-01	Icelandic
Transactions of Managers and Closely Associated Persons Director's Dealing	2026-04-01	English
d Director's Dealing	2026-04-01	English
Alvotech birtir ársreikning á eyðublaði 20-F Report Publication Announcement	2026-03-31	Icelandic
Alvotech files Annual Report with the SEC Report Publication Announcement	2026-03-31	English
Alvotech birtir ársskýrslu fyrir árið 2025 Report Publication Announcement	2026-03-31	Icelandic
Alvotech Publishes 2025 Annual Report Report Publication Announcement	2026-03-31	English
6-K - Alvotech (0001898416) (Filer) Regulatory Filings	2026-03-19	English
Alvotech birtir uppgjör ársins 2025 og fjórða ársfjórðungs Earnings Release Q4 2025	2026-03-18	Icelandic
Alvotech Q4 2025 and Full Year 2025 Financial Results Earnings Release Q4 2025	2026-03-18	English
VOT Share Issue/Capital Change	2026-03-17	English
Alvotech kynnir uppgjör ársins 2025 þann 19. mars nk. Report Publication Announcement	2026-03-04	Icelandic
Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results Report Publication Announcement	2026-03-04	English
v Director's Dealing	2026-03-03	English
as Share Issue/Capital Change	2026-03-02	English
Viðskipti stjórnenda og tengdra aðila Director's Dealing	2026-02-26	Icelandic
Transactions of Managers and Closely Associated Persons Director's Dealing	2026-02-26	English
MANAGERS' TRANSACTIO NOTIFICATION Director's Dealing	2026-02-12	English
Alvotech tilkynnir um aukningu í fjölda eigin bréfa Share Issue/Capital Change	2026-02-11	Icelandic
Alvotech Announces Increase in Number of Own Shares Share Issue/Capital Change	2026-02-11	English
Alvotech kynnir jákvæða niðurstöðu rannsóknar á lyfjahvörfum AVT80, fyrirhugaðrar hliðstæðu við líftæknilyfið Entyvio Regulatory Filings	2026-02-05	Icelandic
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio® Regulatory Filings	2026-02-05	English
6-K Filing Regulatory Filings	2026-02-05	English
Alvotech gerir samninga um markaðssetningu á fyrirhuguðum hliðstæðum í Kanada, Ástralíu og Nýja-Sjálandi Regulatory Filings	2026-02-02	Icelandic
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates Regulatory Filings	2026-02-02	English
6-K Filing Regulatory Filings	2026-02-02	English
Alvotech nær samningum um alþjóðlega markaðssetningu hliðstæðu við augnlyfið Eylea Regulatory Filings	2026-01-29	Icelandic
Alvotech Secures Settlement Agreement in Global Markets for its Biosimilar to Eylea® 2mg Regulatory Filings	2026-01-29	English
6-K Filing Regulatory Filings	2026-01-29	English
FORM 6-K Regulatory Filings	2026-01-07	English
Leiðrétting: Viðskipti stjórnenda og tengdra aðila Director's Dealing	2026-01-07	Icelandic
Correction: Transactions of Managers and Closely Associated Persons Director's Dealing	2026-01-07	English
FORM 6-K Regulatory Filings	2026-01-07	English
FORM 6-K Regulatory Filings	2026-01-06	English
Alvotech tilkynnir breytingar á yfirstjórn félagsins Board/Management Information	2026-01-06	Icelandic
Alvotech announces planned CEO succession and leadership transition Board/Management Information	2026-01-06	English
MTN ATP 19.12 Director's Dealing	2026-01-05	English
MTN Alvogen 17.12 Director's Dealing	2026-01-05	English
MTN ATP 17.12 Director's Dealing	2026-01-05	English
FORM 6-K Regulatory Filings	2026-01-02	English